Can MS Patients Safety Take mRNA-based COVID-19 Vaccines?

Can MS Patients Safety Take mRNA-based COVID-19 Vaccines

Are the current mRNA-based vaccines authorized for emergency use by the U.S. Food and Drug Administration (FDA) safe for those diagnosed with multiple sclerosis (MS)? Especially for those currently taking disease modifying therapies (DMTs)? This is no trivial matter as TrialSite is frequented by hundreds of community members with a MS diagnosis—they want to know. While the two mRNA-based vaccine candidates (Pfizer/BioNTech and Moderna), currently authorized for emergency use, are generally deemed safe and effective for a vast majority of the population, what about for people diagnosed with MS, presently on disease modifying treatments (DMTs)? Recently, a statement made at the annual meeting of the America’s Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS Forum 2021) was cause for throught. Amit Bar-Or, MD, shared that some DMTs could affect COVID-19 responses, which “may be influenced by the timing of the vaccine relative to the treatment.” The National MS Society offers guidance for further clarity. TrialSite provides a brief survey of the current thinking on the topic via the breakdown.

While MS patient identification wasn’t part of the data collection ass...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee